HealthStream Analyst Price Targets

Wall Street analyst price targets and consensus rating for HealthStream (HSTM).

Price Target Range — 9 Quarters

Analyst Consensus — 4 Analysts

1Buy

3Hold

Consensus RatingHold# Analysts4Avg. Consensus PT$32Upside to Avg. PT-5.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 13, 2026	Freedom Capital Markets	Gene Mannheimer	Initiate	Hold	$36
Jul 21, 2026	Canaccord Genuity	Richard Close	PT Raise	Hold	$24→$27
May 6, 2026	Canaccord Genuity	Richard Close	PT Raise	Hold	$21→$24
Dec 17, 2025	Canaccord Genuity	Richard Close	Maintained	Hold	$28
Aug 7, 2025	Canaccord Genuity	Richard Close	PT Cut	Hold	$29→$28
May 15, 2025	Canaccord Genuity	Richard Close	PT Cut	Hold	$30→$29
Feb 26, 2025	Canaccord Genuity	Richard Close	PT Raise	Hold	$29→$30
Feb 6, 2025	JMP Securities	Constantine Davides	Maintained	Market Perform	—
Oct 23, 2024	Barclays	—	PT Raise	Overweight	$32→$34
Oct 23, 2024	Canaccord Genuity	Richard Close	PT Raise	Hold	$28→$29
Jul 24, 2024	Canaccord Genuity	Richard Close	PT Raise	Hold	$27→$28
Dec 6, 2023	JMP Securities	Constantine Davides	Initiate	Market Perform	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Freedom Capital Markets Initiates Coverage On HealthStream with Hold Rating, Announces Price Target of $36

Freedom Capital Markets analyst Gene Mannheimer initiates coverage on HealthStream (NASDAQ:HSTM) with a Hold rating and announces Price Target of $36.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $27

Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and raises the price target from $24 to $27.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $24

Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and raises the price target from $21 to $24.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on HealthStream, Maintains $28 Price Target

Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and maintains $28 price target.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $28

Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and lowers the price target from $29 to $28.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $29

Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and lowers the price target from $30 to $29.

Benzinga Newsdesk

HealthStream Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

HealthStream Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Freedom Capital Markets Initiates Coverage On HealthStream with Hold Rating, Announces Price Target of $36

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $27

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $24

PRO
Canaccord Genuity Maintains Hold on HealthStream, Maintains $28 Price Target

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $28

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $29

People Also Watch

People Also Watch

HealthStream Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

HealthStream Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROFreedom Capital Markets Initiates Coverage On HealthStream with Hold Rating, Announces Price Target of $36

PROCanaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $27

PROCanaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $24

PROCanaccord Genuity Maintains Hold on HealthStream, Maintains $28 Price Target

PROCanaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $28

PROCanaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $29

People Also Watch

People Also Watch

PRO
Freedom Capital Markets Initiates Coverage On HealthStream with Hold Rating, Announces Price Target of $36

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $27

PRO
Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $24

PRO
Canaccord Genuity Maintains Hold on HealthStream, Maintains $28 Price Target

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $28

PRO
Canaccord Genuity Maintains Hold on HealthStream, Lowers Price Target to $29